SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,692.49 -71.74
( -0.10%)

Global Indices

Nasdaq

52,403.42 -403.65
(-0.76%)

Dow Jones

7,657.83 -36.69
(-0.48%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.74 0.23
(0.24%)

EUR-INR

110.11 0.28
(0.26%)

GBP-INR

128.27 0.39
(0.30%)

JPY-INR

0.62 0.01
(0.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

23.9

181.53

EPS(TTM)

Face Value()

Div & Yield %

4.77

1.05

Back

Federal-Mogul Goetze (India) consolidated net profit rises 0.49% in the June 2026 quarter

Aug 13,2026

Net profit of Federal-Mogul Goetze (India) rose 0.49% to Rs 43.46 crore in the quarter ended June 2026 as against Rs 43.25 crore during the previous quarter ended June 2025. Sales rose 8.81% to Rs 526.27 crore in the quarter ended June 2026 as against Rs 483.67 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	526.27	483.67	9
OPM %	12.82	14.59	-
PBDT	82.27	83.07	-1
PBT	61.24	61.01	0
NP	43.46	43.25	0

74,692.49 -71.74 ( -0.10%)

52,403.42 -403.65 (-0.76%)

7,657.83 -36.69 (-0.48%)

65,089.68 -179.65 (-0.28%)

10,664.98 -146.68 (-1.36%)

94.74 0.23 (0.24%)

110.11 0.28 (0.26%)

128.27 0.39 (0.30%)

0.62 0.01 (0.94%)